Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure

Alexander Koch; Henning W. Zimmermann; Nikolaus Gassler; Christoph Jochum; Ralf Weiskirchen; Jan Bruensing; Lukas Buendgens; Hanna Dückers; Tony Bruns; Guido Gerken; Ulf P. Neumann; David H. Adams; Christian Trautwein; Ali Canbay; Frank Tacke

doi:10.1111/liv.12512

Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure

Liver International ◽

10.1111/liv.12512 ◽

2014 ◽

Vol 34 (9) ◽

pp. 1330-1339 ◽

Cited By ~ 31

Author(s):

Alexander Koch ◽

Henning W. Zimmermann ◽

Nikolaus Gassler ◽

Christoph Jochum ◽

Ralf Weiskirchen ◽

...

Keyword(s):

Liver Failure ◽

Acute Liver Failure ◽

Plasminogen Activator ◽

Clinical Relevance ◽

Urokinase Plasminogen Activator ◽

Urokinase Plasminogen Activator Receptor ◽

Cellular Source ◽

Plasminogen Activator Receptor

Download Full-text

Soluble urokinase plasminogen activator receptor is a marker for severity of liver fibrosis in hepatitis C infection

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1263888 ◽

2010 ◽

Vol 48 (08) ◽

Author(s):

ML Berres ◽

B Schlosser ◽

T Berg ◽

C Trautwein ◽

HE Wasmuth

Keyword(s):

Hepatitis C ◽

Liver Fibrosis ◽

Plasminogen Activator ◽

Urokinase Plasminogen Activator ◽

Hepatitis C Infection ◽

Urokinase Plasminogen Activator Receptor ◽

Plasminogen Activator Receptor

Download Full-text

The role of soluble urokinase plasminogen activator receptor as an early biomarker of severity and organ failure in patients with acute pancreatitis

10.26226/morressier.57c5383fd462b80296c9bd2a ◽

2016 ◽

Author(s):

Amir Soleimani

Keyword(s):

Acute Pancreatitis ◽

Organ Failure ◽

Plasminogen Activator ◽

Urokinase Plasminogen Activator ◽

Urokinase Plasminogen Activator Receptor ◽

Early Biomarker ◽

Plasminogen Activator Receptor

Download Full-text

Faculty Opinions recommendation of RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1029099.342534 ◽

2005 ◽

Author(s):

Richard L Stevens

Keyword(s):

Prostate Cancer ◽

Rna Interference ◽

Plasminogen Activator ◽

Cell Invasion ◽

Prostate Cancer Cell ◽

Urokinase Plasminogen Activator ◽

Cancer Cell Invasion ◽

Urokinase Plasminogen Activator Receptor ◽

Plasminogen Activator Receptor

Download Full-text

Faculty Opinions recommendation of Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1033797.388968 ◽

2006 ◽

Author(s):

Arthur Frankel

Keyword(s):

Growth Factor ◽

Tumor Growth ◽

Pancreatic Carcinoma ◽

Plasminogen Activator ◽

Urokinase Plasminogen Activator ◽

Carcinoma Cells ◽

Migration And Invasion ◽

Urokinase Plasminogen Activator Receptor ◽

Factor I ◽

Plasminogen Activator Receptor

Download Full-text

Faculty Opinions recommendation of Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1053811.505747 ◽

2006 ◽

Author(s):

Lindsey A Miles

Keyword(s):

Crystal Structure ◽

Plasminogen Activator ◽

Urokinase Plasminogen Activator ◽

Urokinase Plasminogen Activator Receptor ◽

Plasminogen Activator Receptor

Download Full-text

Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department

Journal of Emergency Medicine ◽

10.1016/j.jemermed.2021.03.012 ◽

2021 ◽

Author(s):

Marius Ahm Stauning ◽

Izzet Altintas ◽

Thomas Kallemose ◽

Jesper Eugen-Olsen ◽

Mette Bendtz Lindstrøm ◽

...

Keyword(s):

Emergency Department ◽

Plasminogen Activator ◽

Early Discharge ◽

Urokinase Plasminogen Activator ◽

Urokinase Plasminogen Activator Receptor ◽

Plasminogen Activator Receptor

Download Full-text

Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer

EJNMMI Research ◽

10.1186/s13550-020-00673-7 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

V. M. Baart ◽

R. D. Houvast ◽

L. F. de Geus-Oei ◽

P. H. A. Quax ◽

P. J. K. Kuppen ◽

...

Keyword(s):

Molecular Imaging ◽

Plasminogen Activator ◽

Urokinase Plasminogen Activator ◽

Urokinase Plasminogen Activator Receptor ◽

Plasminogen Activator Receptor

Download Full-text

Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study

Schizophrenia Research ◽

10.1016/j.schres.2020.11.051 ◽

2021 ◽

Vol 228 ◽

pp. 190-192

Author(s):

Therese Torgersen Bigseth ◽

Mats Fredriksen ◽

Jens Egeland ◽

Eivind Andersen ◽

Ole Andreas Andreassen ◽

...

Keyword(s):

Plasminogen Activator ◽

Case Control Study ◽

Urokinase Plasminogen Activator ◽

Case Control ◽

Low Grade ◽

Inflammation Marker ◽

Urokinase Plasminogen Activator Receptor ◽

Plasminogen Activator Receptor ◽

Low Grade Inflammation ◽

Control Study

Download Full-text

Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis

Pancreas ◽

10.1097/mpa.0000000000001247 ◽

2019 ◽

Vol 48 (3) ◽

pp. 335-342 ◽

Cited By ~ 1

Author(s):

Ding Long ◽

Yujun Wang ◽

Hui Wang ◽

Xiaoling Wu ◽

Li Yu

Keyword(s):

Acute Pancreatitis ◽

Plasminogen Activator ◽

Disease Severity ◽

Ascitic Fluid ◽

Severe Acute Pancreatitis ◽

Inflammatory Markers ◽

Urokinase Plasminogen Activator ◽

Soluble Form ◽

Urokinase Plasminogen Activator Receptor ◽

Plasminogen Activator Receptor

Download Full-text

Experimental Diabetes Causes Breakdown of the Blood-Retina Barrier by a Mechanism Involving Tyrosine Nitration and Increases in Expression of Vascular Endothelial Growth Factor and Urokinase Plasminogen Activator Receptor

American Journal Of Pathology ◽

10.1016/s0002-9440(10)64332-5 ◽

2003 ◽

Vol 162 (6) ◽

pp. 1995-2004 ◽

Cited By ~ 136

Author(s):

Azza B. El-Remessy ◽

M. Ali Behzadian ◽

Gamal Abou-Mohamed ◽

Telina Franklin ◽

Robert W. Caldwell ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Plasminogen Activator ◽

Experimental Diabetes ◽

Urokinase Plasminogen Activator ◽

Tyrosine Nitration ◽

Vascular Endothelial ◽

Urokinase Plasminogen Activator Receptor ◽

Plasminogen Activator Receptor ◽

Endothelial Growth Factor

Download Full-text